United Kingdom · Founded 2015 · Privately Held (backing)
Developer of advanced cancer treatment intended for targeting hard-to-treat cancers. Pheon Therapeutics is based in United Kingdom and was founded in 2015. Its last known valuation is $173 million. It has raised $191 million.
Last price · $/share
—
Implied valuation
$172.7M
Total raised
$191.1M
Last round
—
Cap table — not yet on record
Pheon Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pheon Therapeutics with a free account
·The complete investor list: 11 names
·Watch Pheon Therapeutics: the Monday email on marks, rounds and moves
